2018 AVBCC Summit


October 30-31, 2018 | New York Athletic Club, New York, NY

The Association for Value-Based Cancer Care (AVBCC) invites you to attend the 2018 AVBCC Summit in New York, NY on October 30-31, 2018. This is a prime opportunity to gain a thorough understanding of the evolution of the value equation as it relates to cancer therapies and discover how to implement, improve, and sustain your company or institution, while improving access for patients and ultimately patient care.

Top 3 Reasons to Attend the 2018 AVBCC Conference

  • Stay competitive in the ever-changing field of oncology participating in sessions on topics including Health Policy, Telemedicine, Practice Management, Oncology Specialty Pharmacy and Supply Chain, and more.
  • Learn from stakeholders within the cancer care spectrum, including practitioners, pharmacists, payers, and policymakers to improve patient care and maximize patient access and outcomes through care coordination.
  • Network with nationally recognized experts, faculty speakers, panelists, key opinion leaders, C-suite executives, and managers to exchange best practices in advanced value-based performance and quality measures in cancer care.

No other meeting brings together so many key perspectives in cancer care.

Register Today!

Meeting Highlights

Invited Keynotes

  • Scott Gottlieb, MD, FDA Commissioner
  • Clifford Hudis, MD, FACP, CEO, ASCO
  • Greg Simon, President, Biden Cancer Initiative

Distinguished Researchers Panel

  • Moderator: Neil Canavan, Author, The Cure Within
  • Panelists:
    • Jedd Wolchok, MD, Memorial Sloan Kettering Cancer Center
    • Luis Diaz, MD, Memorial Sloan Kettering Cancer Center
    • Axel Hoos, MD, President, Oncology, GlaxoSmithKline


  • Burt Zweigenhaft
    Managing Partner, Upstream Partners; Co-Founder, AVBCC
  • Michael Kolodziej, MD
    VP and Chief Innovation Officer, ADVI Health LLC


  • William McGivney
    Principal, McGivney Global Advisors
  • Jayson Slotnik, JD, MPH
    Managing Partner, Health Policy Strategies

Co-Chair Perspectives by Cancer Care Ecosystem Stakeholders

  • Peter Bach, MD, Memorial Sloan Kettering Cancer Center
  • Ray Bailey, BPharm, RPh, Pharmacy Director, Florida Cancer Specialists
  • Barry Brooks, MD, Chairman, Contracting Subcommittee, US Oncology Network
  • Brenton Fargnoli, MD, Director, Product Marketing & Strategy/Medical Director, Value-Based Care, Flatiron Health
  • Clifford Houdis, MD, FACP, FASCO, CEO, American Society of Clinical Oncology
  • Douglas Long, VP, Industry Relations, IQVIA
  • Bryan Loy, MD, MBA, VP, Oncology, Laboratory and Personalized Medicine
  • Dan Mendelson, Founder, President, Avalere Health
  • Vince Miller, MD, CMO, Foundation Medicine
  • Everett Neville, Executive VP, Strategy, Supply Chain & Specialty, Express Scripts
  • Steven Pearson, MD, MSc, Founder, President, Institute for Clinical & Economic Review
  • Bruce Pyenson, FSA, MAAA, Principal, Consulting Actuary, Milliman
  • Jeffrey Scott, MD, CMO, Integra Connect
  • Greg Simon, President, Biden Cancer Initiative
  • Surya Singh, MD, Corporate VP, Medical Benefit Management, CVS Caremark
  • Diane Verilli, SVP, Payer and Practice Management Solutions, McKesson Specialty Health